Cano Health (NYSE:CANO) saw an upward trend in its stock price on Monday following the announcement of Mark Kent, the former chief strategy officer, as its new CEO. Kent assumed the role of interim CEO after Marlow Hernandez's departure in June. Hernandez will also step down from the board of directors. The changes are effective immediately. The board stated that Kent's leadership during this critical time has proven his suitability for the
role. Prior to joining, Kent played a significant role in three healthcare startups focused on value-based care. Earlier this month, CANO shares faced a decline after concerns were raised about its ongoing operations.
Comments